يعرض 1,981 - 2,000 نتائج من 21,342 نتيجة بحث عن '(( significant ((rates decrease) OR (greatest decrease)) ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1981
  2. 1982
  3. 1983

    Unmatched kernel density function diagram. حسب Yanling Li (269030)

    منشور في 2025
    الموضوعات:
  4. 1984
  5. 1985

    Dataset (Figs 2–5). حسب Xianyong Wang (22601067)

    منشور في 2025
    "…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …"
  6. 1986

    Schematic diagram of soil sample collection. حسب Xianyong Wang (22601067)

    منشور في 2025
    "…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …"
  7. 1987

    Changes in the neutrophil count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  8. 1988

    Changes in the platelet count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  9. 1989

    Changes in the white blood cell count. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  10. 1990

    Changes in the hemoglobin. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  11. 1991

    WBC and ANC on day 7 post-chemotherapy. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  12. 1992

    General clinical data of 88 patients with NPC. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  13. 1993

    CONSORT participant flow diagram. حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  14. 1994

    S4 File - حسب Lu Yang (30847)

    منشور في 2025
    "…</p><p>Conclusions</p><p>The preventive use of PEG-rhG-CSF decreases the incidence of neutropenia in patients undergoing concurrent chemoradiotherapy for NPC, thereby reducing rates of chemotherapy delays and radiotherapy interruptions, with mild adverse reactions that are tolerable by patients.…"
  15. 1995

    Source data - حسب Desheng Xie (21439869)

    منشور في 2025
    الموضوعات:
  16. 1996
  17. 1997
  18. 1998
  19. 1999
  20. 2000